These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15380956)

  • 1. HIV/AIDS: the private sector is vital.
    England R
    Lancet; 2004 Sep 18-24; 364(9439):1033-4. PubMed ID: 15380956
    [No Abstract]   [Full Text] [Related]  

  • 2. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
    Calmy A; Klement E; Teck R; Berman D; Pécoul B; Ferradini L
    AIDS; 2004 Dec; 18(18):2353-60. PubMed ID: 15622311
    [No Abstract]   [Full Text] [Related]  

  • 3. Directly observed therapy for HIV/tuberculosis co-infection.
    Lurie MN; Carter EJ; Cohen J; Flanigan TP
    Lancet Infect Dis; 2004 Mar; 4(3):137-8. PubMed ID: 14998498
    [No Abstract]   [Full Text] [Related]  

  • 4. Learning and doing: operational research and access to HIV treatment in Africa.
    Katzenstein D; Koulla-Shiro S; Laga M; Moatti JP
    AIDS; 2010 Jan; 24 Suppl 1():S1-4. PubMed ID: 20023435
    [No Abstract]   [Full Text] [Related]  

  • 5. Combining evidence for access to and benefits from antiretroviral treatment to inform planning.
    ; Marlink R; Forsythe S; Bertozzi SM; Muirhead D; Holmes M; Sturchio J
    AIDS; 2008 Jul; 22 Suppl 1():S121-2. PubMed ID: 18664943
    [No Abstract]   [Full Text] [Related]  

  • 6. Hard choices: rationing antiretroviral therapy for HIV/AIDS in Africa.
    Rosen S; Sanne I; Collier A; Simon JL
    Lancet; 2005 Jan 22-28; 365(9456):354-6. PubMed ID: 15664233
    [No Abstract]   [Full Text] [Related]  

  • 7. Rationing antiretroviral therapy in Africa--treating too few, too late.
    Ford N; Mills E; Calmy A
    N Engl J Med; 2009 Apr; 360(18):1808-10. PubMed ID: 19403900
    [No Abstract]   [Full Text] [Related]  

  • 8. WHO urges developing countries to invest in health.
    Kapp C
    Lancet; 2003 Nov; 362(9395):1557. PubMed ID: 14626996
    [No Abstract]   [Full Text] [Related]  

  • 9. WHO puts HIV/AIDS pandemic at top of its agenda.
    Zarocostas J
    Lancet; 2004 May; 363(9421):1615. PubMed ID: 15146891
    [No Abstract]   [Full Text] [Related]  

  • 10. The "free by 5" campaign for universal, free antiretroviral therapy.
    Whiteside A; Lee S
    PLoS Med; 2005 Aug; 2(8):e227. PubMed ID: 16008506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A report on the Zimbabwe Antiretroviral Therapy (ART) programme progress towards achieving MGD6 target 6B: achievement and challenges.
    Apollo T; Takarinda K; Mugurungi O; Chakanyuka C; Simbini T; Harries AD
    Cent Afr J Med; 2010; 56(1-4):12-4. PubMed ID: 23457867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Brazilian experiment: HIV drugs for all.
    Flaer PJ; Younis MZ
    J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access to antiretroviral treatment in Africa.
    Loewenson R; McCoy D
    BMJ; 2004 Jan; 328(7434):241-2. PubMed ID: 14751875
    [No Abstract]   [Full Text] [Related]  

  • 14. Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis.
    Gupta R; Irwin A; Raviglione MC; Kim JY
    Lancet; 2004 Jan; 363(9405):320-4. PubMed ID: 14751708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seizing the opportunity to capitalise on the growing access to HIV treatment to expand HIV prevention.
    Gayle H; Lange JM
    Lancet; 2004 Jul 3-9; 364(9428):6-8. PubMed ID: 15234835
    [No Abstract]   [Full Text] [Related]  

  • 16. Current world literature.
    Curr Opin HIV AIDS; 2010 May; 5(3):261-3. PubMed ID: 20539084
    [No Abstract]   [Full Text] [Related]  

  • 17. Predicting the failure of 3 by 5.
    Brown RC; Brown JE
    Lancet; 2005 Jul 9-15; 366(9480):117-8. PubMed ID: 16005323
    [No Abstract]   [Full Text] [Related]  

  • 18. Leveraging the private health sector to enhance HIV service delivery in lower-income countries.
    Rao P; Gabre-Kidan T; Mubangizi DB; Sulzbach S
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S116-9. PubMed ID: 21857294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patents versus patients? Antiretroviral therapy in India.
    Havlir DV; Hammer SM
    N Engl J Med; 2005 Aug; 353(8):749-51. PubMed ID: 16120852
    [No Abstract]   [Full Text] [Related]  

  • 20. "3 by 5" should be replaced by "Free by 5".
    Bosch X
    Lancet Infect Dis; 2005 Feb; 5(2):76. PubMed ID: 15702506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.